GSK (GSK) Options Chain & Prices $52.23 -0.81 (-1.53%) Closing price 03:59 PM EasternExtended Trading$52.83 +0.61 (+1.16%) As of 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Options Chain Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock GSK Put and Call Options List 1/21/2028 1/15/2027 11/20/2026 8/21/2026 7/31/2026 7/24/2026 7/17/2026 7/10/2026 7/2/2026 6/26/2026 6/18/2026 Options Date Put and Call Options Put Options Call Options Options Type All In The Money Out of The Money Moneyness With Volume Without Volume All Volume Strike Price Min Strike Price Max Export ExpiresStrike PriceClose PricePut/CallVolumeVolume AskVolume BidOpen InterestImplied VolatilityDeltaTrades6/18/2026$42.00$10.314Call4 - - 13(+12)111.09% (+21.80%)0.98717446/18/2026$43.00$9.318Call2 - - 12(+12)102.48% (+19.62%)0.98438926/18/2026$45.00$7.330Call294 - - 250(+0)85.55% (+15.29%)0.97571546/18/2026$45.50$6.833Call297110(+0)81.37% (+14.21%)0.97252676/18/2026$46.00$0.046Put1 - - 145(+0)77.20% (+13.13%)-0.0320116/18/2026$46.50$5.843Call1 - - 0(+0)73.03% (+12.05%)0.96413916/18/2026$47.00$0.056Put1 - - 1033(+0)68.88% (+10.96%)-0.04223916/18/2026$47.00$5.349Call4 - 2393(+0)68.88% (+10.96%)0.95854636/18/2026$48.00$4.364Call5 - - 32(+0)60.57% (+8.76%)0.94299356/18/2026$48.50$3.875Call1 - - 0(+0)56.42% (+7.64%)0.9319681 Get the Latest News and Ratings for GSK and Related StocksEnter your email address below to receive the latest news and analysts' ratings for GSK and its competitors with MarketBeat's FREE daily newsletter. 6/18/2026$49.00$0.094Put8 - 8395(+1)52.27% (+6.52%)-0.08348946/18/2026$49.00$3.388Call3 - - 53(-1)52.27% (+6.52%)0.9176336/18/2026$49.50$0.112Put5 - 5776(+0)48.12% (+5.38%)-0.10281216/18/2026$49.50$2.906Call1 - - 18(+0)48.12% (+5.38%)0.89856716/18/2026$50.00$0.135Put632522(+53)43.98% (+4.24%)-0.12927766/18/2026$50.00$2.429Call6111261(-30)43.98% (+4.24%)0.87251746/18/2026$51.00$0.217Put4 - 3676(+0)35.95% (+2.06%)-0.22122146/18/2026$51.00$1.511Call1 - 1335(+1)35.95% (+2.06%)0.78256416/18/2026$52.00$0.431Put651155(+31)29.54% (+0.90%)-0.42092726/18/2026$52.00$0.720Call12111365(-1)29.54% (+0.90%)0.58895846/18/2026$53.00$0.997Put12 - 287(+26)29.09% (+3.56%)-0.70438946/18/2026$53.00$0.274Call20124540(+16)29.09% (+3.56%)0.31305796/18/2026$54.00$1.863Put1010 - 25(+25)33.95% (+7.33%)-0.86187716/18/2026$54.00$0.127Call19261999(+0)33.95% (+7.33%)0.15508296/18/2026$55.00$0.073Call2133994(+7)39.93% (+9.63%)0.08685966/18/2026$56.00$0.047Call9 - 931(+0)45.87% (+11.28%)0.05381716/18/2026$59.00$6.780Put2 - 10(+0)62.19% (+15.14%)-0.99078926/18/2026$60.00$7.778Put2110(+0)67.14% (+16.27%)-0.99410526/18/2026$61.00$8.777Put3 - 13(+0)71.87% (+17.35%)-0.99613936/18/2026$62.00$9.776Put1 - - 1(+0)76.41% (+18.38%)-0.9975291End-of-day options data provided by Trade Alert and Intrinio. Related Companies and Tools Related Companies Novartis Options Novo Nordisk A/S Options Sanofi Options argenex Options Takeda Pharmaceutical Options Teva Pharmaceutical Industries Options Revolution Medicines Options BioNTech Options Roivant Sciences Options Insmed Options Options Chain Tools Short Interest TrackerShort Interest IncreasesShort Interest DecreasesUnusual Call VolumeUnusual Put Volume This page (NYSE:GSK) was last updated on 6/15/2026 by MarketBeat.com Staff. From Our PartnersTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredIs SpaceX really worth 1.78 Trillion?With SpaceX approaching a near-$2 trillion valuation, most investors are focused on the IPO itself - but analy...InvestPub | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredThe roadshow starts Monday. This stock isn't ready.The SpaceX roadshow kicks off June 8. Goldman Sachs, the lead underwriter, will present the full S-1 to the wo...Behind the Markets | SponsoredSpaceX is chump change compared to Elon’s $20T ‘iPhone’Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...StocksToTrade | SponsoredTrump just signed itA recent policy development is drawing attention from income-focused investors. According to one analyst, c...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GSK PLC Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share GSK With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GSK Stock Alerts